Evidence map›Paper›PMID 34001535›Full record

ArticleDiabetes care2021

Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes.

Ashby F Walker, Korey K Hood, Matthew J Gurka, Stephanie L Filipp, Claudia Anez-Zabala, Nicolas Cuttriss, Michael J Haller, Xanadu Roque, Diana Naranjo, Gina Aulisio and 9 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05211869 nacompletednot on this mapstarted 2022, after this paper: background citation

T1DTechCHW: Enhancing the Community Health Worker (CHW) Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups (YA-URMs) With Type 1 Diabetes (T1D)

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2022 to 2025Enrolled119ConditionsDiabetes, Type 1 Diabetes, Young Adult, Diabetes MellitusArmsT1D-CATCH
NCT06638099 nacompletednot on this mapstarted 2024, after this paper: background citation

Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes

TypeinterventionalSponsorSan Diego State UniversityRan2024 to 2026Enrolled195ConditionsDiabetes, Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus Type 2 (T2DM)ArmsCGM Toolkit Prescriber Training
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Ashby F WalkerUniversity of Florida Diabetes Institute, Gainesville, FL afwalker@ufl.edu.ORCID 0000-0002-7554-2344
Korey K HoodDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.ORCID 0000-0001-5730-7749
Matthew J GurkaDepartment of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL.ORCID 0000-0002-3371-4582
Stephanie L FilippDepartment of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL.
Claudia Anez-ZabalaDepartment of Pediatrics, University of Florida, Gainesville, FL.
Nicolas CuttrissDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.
Michael J HallerUniversity of Florida Diabetes Institute, Gainesville, FL.ORCID 0000-0002-2803-1824
Xanadu RoqueDepartment of Pediatrics, University of Florida, Gainesville, FL.
Diana NaranjoDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.
Gina AulisioUniversity of Florida Diabetes Institute, Gainesville, FL.ORCID 0000-0001-6536-6554
Ananta AddalaDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.ORCID 0000-0002-0508-4309
Jason KonopackDepartment of Family Medicine, University of Florida, Gainesville, FL.
Sarah WestenDepartment of Clinical and Health Psychology, University of Florida, Gainesville, FL.ORCID 0000-0001-9891-4529
Katarina YabutDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.
Elvira MercadoDepartment of Family Medicine, University of Florida, Gainesville, FL.
Sydney LookCollege of Medicine, University of Florida, Gainesville, FL.
Brian FitzgeraldDepartment of Family Medicine, University of Florida, Gainesville, FL.
Jennifer MaizelCollege of Public Health and Health Professions, University of Florida, Gainesville, FL.
David M MaahsDivision of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.ORCID 0000-0002-4602-7909
University of Florida · USStanford University · USUniversity of Florida Health · US

Funding

Training Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2019 to 2023
$2.1M
NIDDK NIH HHS K12 DK122550
6 · The paper itself

Abstract

objectiveDisparities in type 1 diabetes related to use of technologies like continuous glucose monitors (CGMs) and utilization of diabetes care are pronounced based on socioeconomic status (SES), race, and ethnicity. However, systematic reports of perspectives from patients in vulnerable communities regarding barriers are limited. RESEARCH DESIGN AND

methodsTo better understand barriers, focus groups were conducted in Florida and California with adults ≥18 years old with type 1 diabetes with selection criteria including hospitalization for diabetic ketoacidosis, HbA

resultsOver 50% of participants had not seen an endocrinologist in the past year or were only seen once including during hospital visits. In Florida, there was less technology use overall (38% used CGMs in FL and 63% in CA; 43% used pumps in FL and 69% in CA) and significant differences in pump use by SES (

conclusionsThese findings provide novel insights into the experiences of vulnerable communities and demonstrate the need for multilevel interventions aimed at offsetting disparities in diabetes.

Indexed as

Diabetes Mellitus, Type 1EndocrinologyAdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringHumansMiddle AgedTechnologyBlood Glucose

Identifiers

PMID34001535
PMCPMC8323174
OpenAlexW3159976361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.